Wyeth Says Requested OTC NSAID Labeling May Confuse Consumers
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA-requested NSAID cardiovascular warning may not be adequately supported for ibuprofen, Wyeth says. Agency’s six month implementation deadline is biggest challenge, but “some clarifications of wording may be required” to prevent consumer confusion, Advil marketer adds.